Get started
Author

Stephanie Annett

Observed names: Annett, Stephanie, S. L. Annett, Stephanie L. Annett
ORCID: 0000-0002-5932-251X
Observed ORCID: 0000-0002-5932-251X
OpenAlex ID: A5071021600
The Concise Guide to PHARMACOLOGY 2023/24: Enzymes
2023 · Stephen P. H. Alexander, Doriano Fabbro, et al. · British Journal of Pharmacology · 448
PDF
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes
2021 · Stephen P H Alexander, Doriano Fabbro, et al. · British Journal of Pharmacology · 388
PDF
Mitochondrial arginase-2 is essential for IL-10 metabolic reprogramming of inflammatory macrophages
2021 · Jennifer K. Dowling, Remsha Afzal, et al. · Nature Communications · 170
PDF
Top Notch Targeting Strategies in Cancer: A Detailed Overview of Recent Insights and Current Perspectives
2020 · Gillian Moore, Stephanie Annett, et al. · Cells · 128
PDF
FK506 binding proteins and inflammation related signalling pathways; basic biology, current status and future prospects for pharmacological intervention
2020 · Stephanie Annett, Gillian Moore, et al. · Pharmacology & Therapeutics · 98
Obesity and Cancer Metastasis: Molecular and Translational Perspectives
2020 · Stephanie Annett, Gillian Moore, et al. · Cancers · 85
PDF
Targeting cancer stem cells in the clinic: Current status and perspectives
2018 · Stephanie Annett, Tracy Robson · Pharmacology & Therapeutics · 70
FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4
2019 · Lana McClements, Stephanie Annett, et al. · BMC Cancer · 65
PDF
FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer
2019 · Stephanie Annett, Gillian Moore, et al. · British Journal of Cancer · 63
PDF
Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets
2023 · Yinshuang Chen, Weipeng Wang, et al. · Frontiers in Endocrinology · 59
PDF
Potentiating the Anticancer Properties of Bisphosphonates by Nanocomplexation with the Cationic Amphipathic Peptide, RALA
2016 · Ashley S. Massey, Sreekanth Pentlavalli, et al. · Molecular Pharmaceutics · 47
Pharmaceutical drug development: high drug prices and the hidden role of public funding
2020 · Stephanie Annett · Biologia Futura · 40
Prognostic Significance of Glucocorticoid Receptor Expression in Cancer: A Systematic Review and Meta-Analysis
2021 · Noor Bakour, Frank Moriarty, et al. · Cancers · 38
PDF
The Cancer Stem Cell Niche in Ovarian Cancer and Its Impact on Immune Surveillance
2021 · Srishti Jain, Stephanie L. Annett, et al. · International Journal of Molecular Sciences · 32
PDF
The Role of Peptidyl Prolyl Isomerases in Aging and Vascular Diseases
2015 · Lana McClements, Stephanie Annett, et al. · Current Molecular Pharmacology · 22
Enhancing arginase 2 expression using target site blockers as a strategy to modulate macrophage phenotype
2022 · Chiara De Santi, Frances K. Nally, et al. · Molecular Therapy — Nucleic Acids · 19
PDF
The Immunophilin Protein FKBPL and its Peptide Derivatives are Novel Regulators of Vascular Integrity and Inflammation via Nf-κB Signaling
2021 · Stephanie Annett, Shaun Spence, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 14
PDF
Glycolytic reprogramming fuels myeloid cell-driven hypercoagulability
2023 · Aisling M. Rehill, Gemma Leon, et al. · Journal of Thrombosis and Haemostasis · 12
PDF
Effect of the Rehabilitation Program, ReStOre, on Serum Biomarkers in a Randomized Control Trial of Esophagogastric Cancer Survivors
2021 · Susan A. Kennedy, Stephanie L. Annett, et al. · Frontiers in Oncology · 9
Dexamethasone promotes breast cancer stem cells in obese and not lean mice
2022 · Stephanie Annett, Orla Willis Fox, et al. · Pharmacology Research & Perspectives · 3
PDF
Mammary adipose dysfunction in the dual epidemic of obesity and breast cancer
2025 · Elvina Jeyakumar, Sathyavathi Sundararaju, et al. · Carcinogenesis · 2
PDF
Adipose Tissue and Cancer
2025 · Noor Bakour, Claudine Duggan, et al. · IntechOpen eBooks · 1
PDF
Changes in molecular signature on the ocular surface in response to optimising therapy in aqueous-deficient dry eye disease
2026 · Emily Greenan, Niamh M.C. Connolly, et al. · Experimental Eye Research
A window of opportunity: tear cytokine profiles in chronic ocular graft-versus-host disease
2026 · E. Greenan, F. O’Connell, et al. · Eye
PDF
CRISPR-mediated activation of FKBPL in; 3t3-l1 cells via plasmid DNA and mRNA delivery of dcas 9-VPR
2026 · Wuyun Zhu, Tracy Robson, et al. · Endocrine Abstracts
Works count: 39
Citation count: 1,948
H-index: 17
I10-index: 19
Year
Topic
Type